Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
Recruiting now · Not applicable
Conditions studied: Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION
In brief
The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection. The study will compare the investigational supplement with an active control (whey protein alone) to determine whether the combination formulation provides additional benefits on liver-related biomarkers and clinical assessment. Participants will: Take the investigational supplement or active control daily for 12 weeks. Attend clinic visits every 4 weeks for laboratory testing and clinical evaluations.
Key facts
- Study ID
- NCT07487623
- Run by
- University of Guadalajara
- People needed
- 26
- Starts
- 2025-10-11
- Expected to finish
- 2026-05-15
- Last updated by the study team
- 2026-03-23
Who can join
Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with liver disease secondary to chronic hepatitis C virus infection who attend the outpatient Hepatitis Clinic of the Gastroenterology Department at Hospital Civil Fray Antonio Alcalde.
- Child-Pugh score < 8 points. Age 18-69 years. Both sexes. Signed informed consent.
You may not qualify if…
- Patients with alcohol consumption within the past 6 months. Patients with a history of acute-on-chronic liver failure (ACLF). Patients with persistent hepatic encephalopathy. Patients unable to perform frailty assessments. Patients with refractory ascites. Patients with a history of hepatorenal syndrome. Patients with a history of hepatopulmonary syndrome. Patients with chronic kidney disease. Patients with autoimmune diseases. Patients with any type of cancer. Patients with dementia or other significant mental illnesses. Use of protein supplements or probiotics.
Where it is running
- Hospital Civil de Guadalajara Fray Antonio Alcalde — Guadalajara, Jalisco, Mexico (enrolling)
- Hospital Civil de Guadalajara Fray Antonio Alcalde — Guadalajara, Jalisco, Mexico (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.